DE69828451D1 - Wässrige ophthalmische formulierungen mit chitosan - Google Patents

Wässrige ophthalmische formulierungen mit chitosan

Info

Publication number
DE69828451D1
DE69828451D1 DE69828451T DE69828451T DE69828451D1 DE 69828451 D1 DE69828451 D1 DE 69828451D1 DE 69828451 T DE69828451 T DE 69828451T DE 69828451 T DE69828451 T DE 69828451T DE 69828451 D1 DE69828451 D1 DE 69828451D1
Authority
DE
Germany
Prior art keywords
aqueous ophthalmic
chitosan
ophthalmic formulation
ophthalmic formulations
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69828451T
Other languages
English (en)
Other versions
DE69828451T2 (de
Inventor
Robert Gurny
Olivia Felt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Medidom SA
Original Assignee
Laboratoire Medidom SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Medidom SA filed Critical Laboratoire Medidom SA
Publication of DE69828451D1 publication Critical patent/DE69828451D1/de
Application granted granted Critical
Publication of DE69828451T2 publication Critical patent/DE69828451T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
DE69828451T 1998-11-20 1998-11-20 Wässrige ophthalmische formulierungen mit chitosan Expired - Lifetime DE69828451T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1998/001886 WO2000030609A1 (en) 1998-11-20 1998-11-20 Aqueous ophthalmic formulations comprising chitosan

Publications (2)

Publication Number Publication Date
DE69828451D1 true DE69828451D1 (de) 2005-02-03
DE69828451T2 DE69828451T2 (de) 2006-01-12

Family

ID=11004783

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69828451T Expired - Lifetime DE69828451T2 (de) 1998-11-20 1998-11-20 Wässrige ophthalmische formulierungen mit chitosan

Country Status (9)

Country Link
EP (1) EP1128809B1 (de)
AT (1) ATE285751T1 (de)
AU (1) AU1169999A (de)
DE (1) DE69828451T2 (de)
DK (1) DK1128809T3 (de)
ES (1) ES2234164T3 (de)
PT (1) PT1128809E (de)
SI (1) SI1128809T1 (de)
WO (1) WO2000030609A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020018732A1 (en) * 2000-04-21 2002-02-14 Hung William M. Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
DE60002448T2 (de) * 2000-05-26 2004-03-25 Laboratoire Medidom S.A. Antibakterielle wässerige ophtalmische Formulierungen mit Ofloxacin und Chitosan
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
WO2007002345A2 (en) * 2005-06-21 2007-01-04 Bausch & Lomb Incorporated Method for improving water solubility of chitosan
US20170128481A9 (en) * 2009-03-06 2017-05-11 Insite Vision Corporation Ocular treatment with reduced intraocular pressure
EP2555760B1 (de) * 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan-derivaten zur behandlung von mukositis oder ulceration
WO2014047506A1 (en) 2012-09-20 2014-03-27 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
WO2016066195A1 (en) * 2014-10-29 2016-05-06 Laboratoire Medidom Sa Heat-sterilized formulation comprising chitosan and process of preparation thereof
WO2017218942A1 (en) * 2016-06-16 2017-12-21 Eye Care International, Llc Compositions and methods of treating dry syndrome and other traumatized non-keratinized epithelial surfaces

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
CH675535A5 (de) * 1988-11-28 1990-10-15 Nestle Sa
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system

Also Published As

Publication number Publication date
PT1128809E (pt) 2005-04-29
AU1169999A (en) 2000-06-13
SI1128809T1 (en) 2005-06-30
ES2234164T3 (es) 2005-06-16
ATE285751T1 (de) 2005-01-15
EP1128809B1 (de) 2004-12-29
WO2000030609A1 (en) 2000-06-02
DE69828451T2 (de) 2006-01-12
DK1128809T3 (da) 2005-04-25
EP1128809A1 (de) 2001-09-05

Similar Documents

Publication Publication Date Title
WO2004062589A3 (en) An emollient alcohol skin disinfecting formulation
DE69828451D1 (de) Wässrige ophthalmische formulierungen mit chitosan
WO2008011836A3 (es) Soluciones oftálmicas
ATE546135T1 (de) Hyaluronsäure-nanopartikel
DK0781547T3 (da) Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi
MY130477A (en) Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome
DK0801948T3 (da) Oftalmisk sammensætning med forlænget opholdstid i øjet
RU2012148780A (ru) Композиция хитозана
CA2345466A1 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
BR9804875A (pt) Uso de uma composição e peocesso para tratamento profilático ou de cicatrização de feridas de animais de lactação.
CA2519797A1 (en) Low molecular weight hyaluronic acid for the treatment of nerve damage
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
ATE238767T1 (de) Antibakterielle wässerige ophtalmische formulierungen mit ofloxacin und chitosan
SE9403905D0 (sv) New formulations
CA2413088C (en) Preservative
BRPI0411524A (pt) formulação farmacêutica de amoxicilina e clavulanato, uso de carboximetilcelulose de sódio, e, método de tratar infecção bacteriana em pacientes pediátricos
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
AU727844B2 (en) Brine treatment
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
WO2007033020A3 (en) Ophthalmic formulation for treatment of dry eye

Legal Events

Date Code Title Description
8364 No opposition during term of opposition